Clinical Trial Update: Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial of hydroxychloroquine for individuals at risk of Type 1 diabetes mellitus was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type1 Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2024-04-09